BOLT CIK: 1641281

Bolt Biotherapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.1
FY22:
−76.5
FY23:
−69.5
FY24:
−61.3
FY25:
−39.9
Change from FY21 to FY25
millions USD
FY21:
−232
FY22:
57.9
FY23:
71.0
FY24:
57.6
FY25:
44.3
Change from FY21 to FY25
millions USD
FY21:
311
FY22:
0.50
FY23:
0.25
FY24:
0.11
FY25:
0.02
millions USD
FY21:
21.8
FY22:
−18.1
FY23:
1.77
FY24:
−3.61
FY25:
4.47
(positive)
Change from FY21 to FY25
millions USD
FY21:
−59.4
FY22:
−78.5
FY23:
−69.7
FY24:
−61.3
FY25:
−39.9

All amounts in millions USD Data source:SEC EDGAR